[Elsevier] Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

jakir_ete_ruet Post time 11 min. ago | Show all posts |Read mode
This post will be closed automatically in 2026-11-22 10:24
Reward100points

Title: Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial
DOI: https://doi.org/10.1016/s1474-4422(21)00241-6

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
sfh0012 Post time 11 min. ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    204825


Return to the list